Health ❯Healthcare ❯Pharmaceuticals ❯Drug Pricing

Market Competition

Mounjaro Price Hike Triggers Stockpiling and Shift to Ozempic and Wegovy

Retail list-price rises of up to 170% have driven privately paying patients to bulk-buy and risk unsafe drug switches.

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices